RISalud
Institutional Health Repository of Andalucía
Browsing by Author Rodríguez-Baño, J
Showing results 1 to 20 of 29
next >
| Preview | Title | Author(s) | Issue Date |
|---|---|---|---|
| A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. | Bartoletti, M; Giannella, M; Lewis, R; Caraceni, P; Tedeschi, S; Paul, M; Schramm, C; Bruns, T; Merli, M; Cobos-Trigueros, N; Seminari, E; Retamar, P; Muñoz, P; Tumbarello, M; Burra, P; Torrani Cerenzia, M; Barsic, B; Calbo, E; Maraolo, A E; Petrosillo, N; Galan-Ladero, M A; D'Offizi, G; Bar Sinai, N; Rodríguez-Baño, J; Verucchi, G; Bernardi, M; Viale, P; ESGBIS/BICHROME Study Group | 14-Aug-2017 | |
| Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. | Papst, L; Beović, B; Pulcini, C; Durante-Mangoni, E; Rodríguez-Baño, J; Kaye, K S; Daikos, G L; Raka, L; Paul, M; ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group | 1-Feb-2018 | |
| Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR). | Gudiol, C; Royo-Cebrecos, C; Tebe, C; Abdala, E; Akova, M; Álvarez, R; Maestro-de la Calle, G; Cano, A; Cervera, C; Clemente, WT; Martín-Dávila, P; Freifeld, A; Gómez, L; Gottlieb, T; Gurguí, M; Herrera, F; Manzur, A; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Ruiz-Camps, I; Sukiennik, TC; Carratalà, J | 23-Jan-2017 | |
| Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR). | Gudiol, C; Royo-Cebrecos, C; Tebe, C; Abdala, E; Akova, M; Álvarez, R; Maestro-de la Calle, G; Cano, A; Cervera, C; Clemente, W T; Martín-Dávila, P; Freifeld, A; Gómez, L; Gottlieb, T; Gurguí, M; Herrera, F; Manzur, A; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Ruiz-Camps, I; Sukiennik, T C; Carratalà, J; BICAR study group | 23-Jan-2017 | |
| Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies. | Moreno-García, E; Puerta-Alcalde, P; Gariup, G; Fernández-Ruiz, M; López Cortés, L E; Cuervo, G; Salavert, M; Merino, P; Machado, M; Guinea, J; García-Rodríguez, J; Garnacho-Montero, J; Cardozo, C; Peman, J; Montejo, M; Fortún, J; Almirante, B; Castro, C; Rodríguez-Baño, J; Aguado, J M; Martínez, J A; Carratalà, J; Soriano, A; Garcia-Vidal, C | 23-May-2022 | |
| Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. | Gutiérrez-Gutiérrez, B; Rodríguez-Baño, J | 12-Apr-2019 | |
| Development and validation of baseline, perioperative and at-discharge predictive models for postsurgical prosthetic joint infection. | Del Toro, M D; Peñas, C; Conde-Albarracín, A; Palomino, J; Brun, F; Sánchez, S; Rodríguez-Baño, J | 30-Apr-2018 | |
| Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort. | López-Cortés, L E; Almirante, B; Cuenca-Estrella, M; Garnacho-Montero, J; Padilla, B; Puig-Asensio, M; Ruiz-Camps, I; Rodríguez-Baño, J; members of the CANDIPOP Project from GEIH-GEMICOMED (SEIMC) and REIPI | 14-May-2016 | |
| Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade. | Martínez Pérez-Crespo, P M; López-Cortés, L E; Retamar-Gentil, P; García, J F Lanz; Vinuesa García, D; León, E; Calvo, J M Sánchez; Galán-Sánchez, F; Natera Kindelan, C; Del Arco Jiménez, A; Sánchez-Porto, A; Herrero Rodríguez, C; Becerril Carral, B; Molina, I M Reche; Iglesias, J M Reguera; Pérez Camacho, I; Guzman García, M; López-Hernández, I; Rodríguez-Baño, J; PROBAC REIPI/GEIH-SEIMC/SAEI Group | 26-May-2020 | |
| ESCMID white paper: a guide on ESCMID guidance documents. | Scudeller, L; Rodríguez-Baño, J; Zinkernagel, A; Tacconelli, Evelina; Akova, M; Friedrich, A W; Sanguinetti, M; Paul, M; Poljak, M | 24-Aug-2018 | |
| ESCMID-an international Europe-based society committed to fostering cross-border collaboration and education to improve patient care. | Poljak, M; Akova, M; Friedrich, A W; Rodríguez-Baño, J; Sanguinetti, M; Tacconelli, E; Zinkernagel, A | 2-Jun-2017 | |
| ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. | Tacconelli, E; Mazzaferri, F; de Smet, A M; Bragantini, D; Eggimann, P; Huttner, B D; Kuijper, E J; Lucet, J-C; Mutters, N T; Sanguinetti, M; Schwaber, M J; Souli, M; Torre-Cisneros, J; Price, J R; Rodríguez-Baño, J | 29-Jan-2019 | |
| First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. | Espinal, P; Macià, M D; Roca, I; Gato, E; Ruíz, E; Fernández-Cuenca, F; Oliver, A; Rodríguez-Baño, J; Bou, G; Tomás, M; Vila, J | Jan-2013 | |
| Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study. | Smit, J; López-Cortés, L E; Kaasch, A J; Søgaard, M; Thomsen, R W; Schønheyder, H C; Rodríguez-Baño, J; Nielsen, H | 22-Jun-2016 | |
| Interplay among Different Fosfomycin Resistance Mechanisms in Klebsiella pneumoniae. | Ortiz-Padilla, M; Portillo-Calderón, I; de Gregorio-Iaria, B; Blázquez, J; Rodríguez-Baño, J; Pascual, A; Rodríguez-Martínez, J M; Docobo-Pérez, F | 17-Feb-2021 | |
| Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres. | Talaminos, A; López-Cerero, L; Calvillo, J; Pascual, A; Roa, L M; Rodríguez-Baño, J | 3-Feb-2016 | |
| Molecular insights into fosfomycin resistance in Escherichia coli. | Ballestero-Téllez, M; Docobo-Pérez, F; Portillo-Calderón, I; Rodríguez-Martínez, J M; Racero, L; Ramos-Guelfo, M S; Blázquez, J; Rodríguez-Baño, J; Pascual, A | 2017 | |
| Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis. | Rodríguez-Baño, J; Pérez-Moreno, M A; Peñalva, G; Garnacho-Montero, J; Pinto, C; Salcedo, I; Fernández-Urrusuno, R; Neth, O; Gil-Navarro, M V; Pérez-Milena, A; Sierra, R; Estella, Á; Lupión, C; Irastorza, A; Márquez, J L; Pascual, Á; Rojo-Martín, M D; Pérez-Lozano, M J; Valencia-Martín, R; Cisneros, J M; PIRASOA Programme Group | 16-Jul-2019 | |
| Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study. | Kostyanev, T; Xavier, B B; García-Castillo, M; Lammens, C; Bravo-Ferrer Acosta, J; Rodríguez-Baño, J; Cantón, R; Glupczynski, Y; Goossens, H; EURECA/WP1B Group | 20-Apr-2021 | |
| Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli. | Merino-Bohórquez, V; Docobo-Pérez, F; Sojo, J; Morales, I; Lupión, C; Martín, D; Cameán, M; Hope, W; Pascual, Á; Rodríguez-Baño, J | 10-Apr-2018 |